Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase 4 4Phase NA 3Phase 3 3Phase EARLY_PHASE1 1Phase 2/3 1Phase 1/2 1

Status

Withdrawn 1Recruiting 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Other hematologic neoplasm 1Classical hematology 1

Conditions

Pancreatic Neoplasms 2Surgical Wound Infection 1Neutropenia 1Neoplasms 1Hematologic Neoplasms 1Febrile Neutropenia 1Dysbiosis 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Interventional × Metronidazole × Clear all
NCT07590648 2026-05-15

E-STOP2

Hospital Universitari Vall d'Hebron Research Institute

Phase 4 Not yet recruiting
136 enrolled
Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

NCT05784311 2024-10-21

SPARROW

Leiden University Medical Center

Phase 4 Recruiting
344 enrolled
Gastrointestinal

Pancreatic Neoplasms, Surgical Wound Infection

NCT04527055 2024-06-24

Bsm10

National Cheng-Kung University Hospital

Phase 4 Enrolling by invitation
312 enrolled

Dysbiosis

NCT03891979 2020-06-26

Gut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy in Pancreatic Adenocarcinoma

NYU Langone Health

Phase 4 Withdrawn
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡